Doherty TM - Search Results

1

The prognosis of latent tuberculosis: can disease be predicted?

Andersen P, Doherty TM, Pai M, Weldingh K. Andersen P, et al. Among authors: doherty tm. Trends Mol Med. 2007 May;13(5):175-82. doi: 10.1016/j.molmed.2007.03.004. Epub 2007 Apr 5. Trends Mol Med. 2007. PMID: 17418641 Review.

2

Tuberculosis vaccines: developmental work and the future.

Doherty TM, Andersen P. Doherty TM, et al. Curr Opin Pulm Med. 2000 May;6(3):203-8. doi: 10.1097/00063198-200005000-00007. Curr Opin Pulm Med. 2000. PMID: 10782704 Review.

3

Specific immune-based diagnosis of tuberculosis.

Andersen P, Munk ME, Pollock JM, Doherty TM. Andersen P, et al. Among authors: doherty tm. Lancet. 2000 Sep 23;356(9235):1099-104. doi: 10.1016/s0140-6736(00)02742-2. Lancet. 2000. PMID: 11009160 Review.

4

Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis.

Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, Cheng WC, Andersen P, Doherty TM. Wu-Hsieh BA, et al. Among authors: doherty tm. Clin Infect Dis. 2001 Oct 15;33(8):1336-40. doi: 10.1086/323044. Epub 2001 Sep 14. Clin Infect Dis. 2001. PMID: 11565073

5

Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Doherty TM, et al. J Clin Microbiol. 2002 Feb;40(2):704-6. doi: 10.1128/jcm.40.2.704-706.2002. J Clin Microbiol. 2002. PMID: 11826002 Free PMC article.

6

Tuberculosis vaccine development.

Doherty TM, Andersen P. Doherty TM, et al. Curr Opin Pulm Med. 2002 May;8(3):183-7. doi: 10.1097/00063198-200205000-00006. Curr Opin Pulm Med. 2002. PMID: 11981306 Review.

7

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis.

Doherty TM, Olsen AW, van Pinxteren L, Andersen P. Doherty TM, et al. Infect Immun. 2002 Jun;70(6):3111-21. doi: 10.1128/iai.70.6.3111-3121.2002. Infect Immun. 2002. PMID: 12011005 Free PMC article.

8

Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights.

Okkels LM, Doherty TM, Andersen P. Okkels LM, et al. Among authors: doherty tm. Curr Pharm Biotechnol. 2003 Feb;4(1):69-83. doi: 10.2174/1389201033377931. Curr Pharm Biotechnol. 2003. PMID: 12570683 Review.

9

The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection.

Rolinck-Werninghaus C, Magdorf K, Stark K, Lyashchenko K, Gennaro ML, Colangeli R, Doherty TM, Andersen P, Plum G, Herz U, Renz H, Wahn U. Rolinck-Werninghaus C, et al. Among authors: doherty tm. Eur J Pediatr. 2003 Jul;162(7-8):534-536. doi: 10.1007/s00431-003-1199-6. Epub 2003 Apr 25. Eur J Pediatr. 2003. PMID: 12715165 No abstract available.

10

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.

Holten-Andersen L, Doherty TM, Korsholm KS, Andersen P. Holten-Andersen L, et al. Among authors: doherty tm. Infect Immun. 2004 Mar;72(3):1608-17. doi: 10.1128/iai.72.3.1608-1617.2004. Infect Immun. 2004. PMID: 14977968 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results